It is my understanding that the name SEID is simply a recommendation and that NIH/HHS would have to act to officially change the name. If that is the case, we have an opportunity to air our concerns before an official name change is made.
I doubt we are going to get much play with the "we don't think it sounds serious enough" argument. They don't care how we feel about the name. We need harder arguments. One strong argument is that Systemic Exertion Intolerance Disease does not translate into other languages at all. We need medical words that have clear meaning in all major languages. Another is that Exertion Intolerance is far too similar to Exercise Intolerance, which is well known in the medical world and therefore much too easily confused leading to misdiagnoses. I'm sure we can come up with other unemotional arguments for a better name.
We are not going to get a new name they feel there is not evidence for. That means anything with myalgic or encephalomyelitis is out. They've already been very clear on that, so let's not waste our time. They may be wrong, but we don't have enough scientific evidence to support using either of those words. It's as simple as that. Neuro-immune is apparently too general for them since other illnesses also affect neurological and immune systems. Neuro-immune exhaustion may fly as more explicit.
I support the WHO's discouragement of eponymous disease official names. It's just better all around to stick to descriptive names. However, since a descriptive name is not really possible with a very complex disease with multiple system involvement AND which has practically no research base, perhaps a temporary eponymous name is in order. They've already admitted that any name currently established is temporary, so do we need to fuss over eponymity at the moment?
Even if we go with an eponymous name, Ramsay's Disease is probably out since there are already too many Ramsay associations in medicine. They simply aren't going to go there, whatever we lay people think. Perhaps some other eponymous name for temporary use would do, say Mirza's Disease after Sophia Mirza. The average person doesn't have to know who Sophia was.
All that said, I think we are both better off with -- and far more likely to get -- a descriptive name. We can whine all we want that that discouragement of eponymous names is unreasonable in our case. It's not going to change their thinking, so we are wasting our energy. We need to choose our battles carefully, especially with our limited energy and resources.
How can we combine our individual efforts most effectively to get the NIH/HHS to give us a name both we and they consider acceptable, even if it isn't ideal? None of us will agree on one single perfect name right now. What do we most want the NIH/HHS to know about a new name? Can we get behind a name, or at least a few simple, logical ideas about a name so that we can present an solid, intelligent front and not sound like a bunch of whiny children ("But we don't liiiiike that name! It doesn't sound important enough!")
And let's not forget that whatever the NIH/HHS decides only applies to the US. This is not a WHO-mandated decision, so it's probably not relevant how the NHS is going to view it (for example). If it doesn't fit their agenda, they are not going to adopt the new name until the WHO forces them to, and that's not going to happen in any big hurry.